What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
TMS not only targets these conditions but also promotes brain health by increasing Brain-Derived Neurotrophic Factor (BDNF)a protein that supports neuroplasticity and overall brain function
Angiogenesis and Vasculogenesis
Wrong reconstitution volume Mistake : Adding 5ml water thinking "5mg = 5ml." Problem : Makes concentration too weak, unnecessarily large injections
If you're ready to ensure your research is built on a rock-solid foundation of quality, from the peptide itself to the diluent you use, we're here to help